The global allergy diagnostics market is expected to reach US$ 5,417.6 Mn. The inhaled allergen segment in the global allergy diagnostics market is estimated to account for the major revenue share of 48.3% in 2017. By product type: Assay kits segment is estimated to register a CAGR of over 13.0%, thereby accounting for highest revenue share among the type segments. By allergen type: Inhaled allergen segment is estimated to account for highest revenue share among the allergen type segments, registering a CAGR of over 12.9% over the forecast period. By region: The market in North America accounted for highest revenue share in the global allergy diagnostic market in 2016, and is expected to record highest CAGR of over 12.3% between 2016 and 2026.
2026 US$ 5,417.6 Mn: Worldwide Allergy Diagnostics Market is expected to reach US$ 5,417.6 Mn in 2026